Readily available info, should really dyor but see below:
DX1 pharmacokinetics in triple negative breast cancer June 2018
Initiate stable cell line development of PAT-DX1 H2 2018
DX1 - Solid cancer (TBC) animal data August 2018
Select target indication for PAT-DX1 clinical development Q3 2018
DX1 – Additional solid cancer (TBC) animal data October 2018
DX1 + Temozolomide + radiation – brain cancer animal data Q4 2018
Note that follow up data to the breast cancer trials could also drop at any time leaving some of the sellers waiting till end of this month to buy back in off guard.
Readily available info, should really dyor but see below: DX1...
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 154511 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 4813825 | 5 |
View Market Depth
| Last trade - 16.12pm 31/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable